Evidence map›Paper›PMID 17565946›Full record

ArticleGenetics2007

Efficient Tor signaling requires a functional class C Vps protein complex in Saccharomyces cerevisiae.

Sara A Zurita-Martinez, Rekha Puria, Xuewen Pan, Jef D Boeke, Maria E Cardenas

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Conceptualizing Eukaryotic Metabolic Sensing and Signaling.Journal of the Indian Institute of Science · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sara A Zurita-MartinezDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Rekha Puria
Xuewen Pan
Jef D Boeke
Maria E Cardenas
Duke University Hospital · USBaylor College of Medicine · USDuke University · USJohns Hopkins University · US

Funding

YEAST GENETIC INTERACTION MAPR01HG002432 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BOEKE, JEF D · 2002 to 2008
$11.8M
Signaling mechanisms by the rapamycin target: Tor kinaseR01CA114107 · NCI · DUKE UNIVERSITY · PI CARDENAS-CORONA, MARIA E · 2005 to 2009
$1.3M
NCI NIH HHS R01 CA 114107NCI NIH HHS R01 CA114107NHGRI NIH HHS HG 002432NHGRI NIH HHS R01 HG002432
6 · The paper itself

Abstract

The Tor kinases regulate responses to nutrients and control cell growth. Unlike most organisms that only contain one Tor protein, Saccharomyces cerevisiae expresses two, Tor1 and Tor2, which are thought to share all of the rapamycin-sensitive functions attributable to Tor signaling. Here we conducted a genetic screen that defined the global TOR1 synthetic fitness or lethal interaction gene network. This screen identified mutations in distinctive functional categories that impaired vacuolar function, including components of the EGO/Gse and PAS complexes that reduce fitness. In addition, tor1 is lethal in combination with mutations in class C Vps complex components. We find that Tor1 does not regulate the known function of the class C Vps complex in protein sorting. Instead class C vps mutants fail to recover from rapamycin-induced growth arrest or to survive nitrogen starvation and have low levels of amino acids. Remarkably, addition of glutamate or glutamine restores viability to a tor1 pep3 mutant strain. We conclude that Tor1 is more effective than Tor2 at providing rapamycin-sensitive Tor signaling under conditions of amino acid limitation, and that an intact class C Vps complex is required to mediate intracellular amino acid homeostasis for efficient Tor signaling.

Indexed as

Adaptor Proteins, Vesicular TransportAmino AcidsBase SequenceCell Cycle ProteinsDNA, FungalDNA PrimersGenes, FungalMembrane ProteinsMultiprotein ComplexesMutationPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionAdaptor Proteins, Vesicular TransportAmino AcidsCell Cycle ProteinsDNA, FungalDNA PrimersMembrane ProteinsMultiprotein ComplexesPEP3 protein, S cerevisiaePEP5 protein, S cerevisiaePhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesSaccharomyces cerevisiae Proteinstarget of rapamycin protein, S cerevisiaeTOR1 protein, S cerevisiaeTOR2 protein, S cerevisiaeVesicular Transport Proteins

Identifiers

PMID17565946
PMCPMC1950620
OpenAlexW2137284085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.